Central PSUs record 47 per cent jump in net profit for 2023-24, market cap doubles
The market capitalisation of CPSEs more than doubled in Fiscal Year 2024-25 as compared to Fiscal Year 2023-24, the report said.
Domestic equity benchmarks on Tuesday extended their winning streak for the seventh day in a row and gained over 1 per cent to end at record high levels. Investors sentiments soared after pharmaceutical major Pfizer’s COVID-19 vaccine trials data.
The S&P BSE Sensex ended 680.22 points or 1.60 per cent higher at 43,277.65. It had earlier touched its lifetime peak of 43,316.44 during the day.
Advertisement
Similarly, NSE Nifty also touched a fresh intra-day high of 12,643.90. It ended at 12,631.10, up 170.05 points or 1.36 per cent.
Advertisement
Bajaj Finance was the top gainer in the Sensex pack, surging around 9 per cent, followed by IndusInd Bank, L&T, Bajaj Finserv, HDFC, SBI, ICICI Bank, HDFC Bank, ONGC and Axis Bank.
On the other hand, Tech Mahindra, HCL Tech, Infosys, Nestle India, Sun Pharma and TCS closed in the red.
“Announcements by BioNTech and Pfizer about successful phase 3 trial of COVID-19 vaccine instilled confidence among investors and possibility of sustained economic recovery led sharp buying in beaten down stocks,” said Arjun Yash Mahajan, Head Institutional Business at Reliance Securities.
Favourable global markets and NDA’s surprising lead in Bihar assembly elections also supported the rally, he added.
However, champions that emerged during pandemic like IT and pharma stocks witnessed sharp profit booking, he noted.
Pfizer and BioNTech on Monday said their vaccine candidate was found to be more than 90 per cent effective in preventing COVID-19.
Elsewhere in Asia, bourses in Hong Kong, Seoul and Tokyo ended with gains, while Shanghai settled lower.
Stock exchanges in Europe were mostly trading on a positive note.
Foreign institutional investors remained net buyers in the capital market as they purchased shares worth Rs 4,548.39 crore on Monday, according to provisional exchange data.
Meanwhile, international oil benchmark Brent crude was trading 1.42 per cent higher at USD 43 per barrel.
Advertisement
